AIM
XLRN

Aigen Investment Management’s Acceleron Pharma XLRN Stock Holding History

Aigen Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8,428
Closed -$757K – 1431
2020
Q1 		$757K Buy
8,428
+4,490
+114% +$349K 0.1% 294
2019
Q4 		$209K Buy
+3,938
New +$180K 0.03% 532

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Aigen Investment Management's XLRN Position: Q2 2020 in Review

Aigen Investment Management sold out of Acceleron Pharma (XLRN) in Q2 2020, closing a stake of 8,428 shares — an estimated $757K sold.

Aigen Investment Management first reported a position in XLRN in Q4 2019 and held it in 2 quarters. The position peaked at $757K in Q1 2020. 242 funds tracked by Wall St. Rank hold XLRN as of Q2 2020.

  • Aigen Investment Management reported no remaining Acceleron Pharma position as of Q2 2020 after selling out during the quarter.
  • Aigen Investment Management sold 8,428 Acceleron Pharma shares in Q2 2020, an estimated $757K.
  • Aigen Investment Management first reported a position in Acceleron Pharma in Q4 2019 and held it in 2 quarters.
  • Aigen Investment Management's Acceleron Pharma position peaked at $757K in Q1 2020.
  • 242 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.